(Q41655617)

English

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.

scientific article published on 19 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Kate Cuschieri

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sam Hibbitts

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Jackie Jamison

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alex Sargent

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kevin G Pollock

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ned Powell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Robbie Wilson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Fiona McCall

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alison Fiander

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kate Soldan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

19 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

135-140

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25410654%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A review of human carcinogens--Part B: biological agents

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202681

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41655617&oldid=1537098189"